Institut Rosell-Lallemand

Lallemand Health Solutions is a global leader in the research, development, and manufacturing of probiotic-based solutions for human health. Originally founded as Institut Rosell in 1934 and acquired by the Lallemand Group in 1998, the company specializes in producing high-quality probiotic strains and finished dosage forms for the dietary supplement, pharmaceutical, and food industries. Their expertise spans several therapeutic areas, including gut health, immunity, mental health (psychobiotics), and women's health. The company operates several GMP-certified production facilities and maintains an extensive internal strain bank and a robust clinical research program through its dedicated research hub, the Rosell Institute for Microbiome and Probiotics.